Patents Assigned to AstraZeneca AB, a Sweden corporation
  • Publication number: 20040254540
    Abstract: An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger.
    Type: Application
    Filed: March 31, 2004
    Publication date: December 16, 2004
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Derek J. Shaw, Brian R. Law
  • Publication number: 20040014783
    Abstract: The present invention provides a compound of a formula (I): 1
    Type: Application
    Filed: May 13, 2003
    Publication date: January 22, 2004
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence
  • Publication number: 20040006080
    Abstract: The present invention provides a compound of a formula (I): 1
    Type: Application
    Filed: January 13, 2003
    Publication date: January 8, 2004
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence
  • Publication number: 20030211972
    Abstract: A method of treating a patient in need of insulin treatment, including the steps of introducing into the lower respiratory tract of the patient an effective amount of a therapeutic preparation in the form of a dry powder containing (a) insulin and (b) an enhancer compound which enhances the absorption of insulin in the lungs of the patient.
    Type: Application
    Filed: March 27, 2003
    Publication date: November 13, 2003
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Kjell Goran Erik Backstrom, Carlos Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Publication number: 20030134840
    Abstract: The invention provides compounds of general formula 1
    Type: Application
    Filed: January 9, 2003
    Publication date: July 17, 2003
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Andrew Baxter, Stephen Brough, Nicholas Kindon, Thomas Mclnally, Bryan Roberts, Stephen Thom